Expert Panel Skeptical About Abuse-Resistant OxyContin

Purdue Pharma went before an FDA panel yesterday to make its case for a rejiggered form of the painkiller OxyContin that the company says is harder to abuse. The panel wasn’t buying it. “I’m fascinated with the poor scientific rigor” of the data presented the company, one panel member reportedly said. “It’s almost insulting.” That’s [...]